TABLE 2.

Characteristics of patients with MDR/RR-TB

Characteristic	Total (n = 200)		Favored outcome (n = 80)		Pending (n = 95)		Died (n = 23)
	No.	%	No.	%	No.	%	No.	%
Gender
Male	148	74.0	59	40.1	71	48.3	17	11.6
Female	52	26.0	21	41.2	24	47.1	6	11.8
Age, yr
15–34	48	24.0	28	58.3	17	35.4	1	2.1
35–54	97	48.5	30	30.9	59	60.8	8	8.2
≥55	55	27.5	22	40.0	19	34.5	14	26.4
Occupation
Others	59	29.5	24	40.7	31	52.5	3	5.1
Farmer	115	57.5	44	38.6	50	43.9	20	17.5
Worker	26	13.0	12	46.2	14	53.8	0	0
Residence
Rural	116	58.0	51	44.3	46	40.0	18	15.7
Urban	84	42.0	29	34.9	49	59.0	5	6.0
Category
Migrant	25	12.5	9	36.0	15	60.0	1	4.0
Resident	175	87.5	71	41.0	80	46.2	22	12.7
Type of patient
Previously treated	152	76.0	60	40.0	71	47.3	19	12.7
New	48	24.0	20	41.7	24	50.0	4	8.3
Lung cavitation
No	119	59.5	54	45.4	54	45.4	11	9.2
Yes	81	40.5	26	32.9	41	51.9	12	15.2
Diabetes mellitus
No	189	94.5	74	39.4	93	49.5	21	11.2
Yes	11	5.5	6	60.0	2	20.0	2	20.0
Diagnosis delay (days)
Above mean	42	21.0	15	35.7	21	50.0	6	14.3
Below mean	158	79.0	65	41.1	74	46.8	17	10.8
Drug susceptibility
MDR/RR-TB	103	51.5	41	39.8	53	51.5	9	8.7
Pre-XDR-TB	92	46.0	37	41.1	39	43.3	14	15.6
XDR-TB	5	2.5	2	40.0	3	60.0	0	0
History of treatments
No drugs	15	7.5	10	66.7	4	26.7	1	6.7
First-line drugs only	127	63.5	53	42.1	57	45.2	16	12.7
Second-line drugs	58	29.0	17	29.8	34	59.6	6	10.5